Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published
BioSpace,
) – Oncoceutics, Inc. announced that results from the second and third cohort of the Phase II trial for patients with recurrent…
First clinical experience with DRD2/3 antagonist ONC201 in H3 K27M-mutant pediatric diffuse intrinsic pontine glioma: a case report.
Overview of attention for article published in Journal of Neurosurgery: Pediatrics, April 2019
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (89th percentile)
-
High Attention Score compared to outputs of the same age and source (87th percentile)
Readers on
- mendeley
- 65 Mendeley